These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19761946)

  • 1. Renal protective effects and prevention of contrast-induced nephropathy by atrial natriuretic peptide can it work?
    Haase M; Haase-Fielitz A; Habedank D; Anker SD
    J Am Coll Cardiol; 2009 Sep; 54(13):1192-3; author reply 1193-4. PubMed ID: 19761946
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.
    Morikawa S; Sone T; Tsuboi H; Mukawa H; Morishima I; Uesugi M; Morita Y; Numaguchi Y; Okumura K; Murohara T
    J Am Coll Cardiol; 2009 Mar; 53(12):1040-6. PubMed ID: 19298916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
    Huisman IA; Stegeman CA; Gans RO; Gansevoort RT
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2329-33. PubMed ID: 16261711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of human atrial natriuretic peptide on renal function in a patient with repeated coronary interventions: a case report.
    Paredes OL; Shite J; Shinke T; Imuro Y; Yoshikawa R; Watanabe S; Ozawa T; Otake H; Matsumoto D; Ogasawara D; Yokoyama M
    J Cardiol; 2005 Oct; 46(4):161-4. PubMed ID: 16252569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
    Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U
    Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735
    [No Abstract]   [Full Text] [Related]  

  • 6. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
    Asher I; Hammerman A; Sthoeger Z
    Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of contrast-induced nephropathy and management of high-risk patients].
    Marenzi G
    G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-induced nephropathy.
    Narang R; Sakhare M; Bahl VK
    Indian Heart J; 2004; 56(1):13-20. PubMed ID: 15129784
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of radiocontrast-induced renal insufficiency.
    Shumate MJ
    N Engl J Med; 1995 Apr; 332(15):1035; author reply 1036. PubMed ID: 7885420
    [No Abstract]   [Full Text] [Related]  

  • 10. Acetylcysteine to prevent acute contrast-induced nephropathy.
    Mears JM
    Am Fam Physician; 2004 Dec; 70(11):2077; author reply 2077. PubMed ID: 15606054
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function.
    Nikolsky E; Aymong ED; Dangas G; Mehran R
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S7-S14. PubMed ID: 12556732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide in gentamicin-induced acute renal failure.
    Schafferhans K; Heidbreder E; Sperber S; Dämmrich J; Heidland A
    Kidney Int Suppl; 1988 Sep; 25():S101-3. PubMed ID: 2972861
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
    Oudemans-van Straaten HM
    Ned Tijdschr Geneeskd; 2006 Feb; 150(5):272-3; author reply 275-6. PubMed ID: 16493994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nephrotoxic action of contrast media].
    Kleinrok A; Kudyk T
    Przegl Lek; 2005; 62 Suppl 2():57-60. PubMed ID: 16623122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
    Hemmelder MH; Hoogendoorn M; Halma C
    Ned Tijdschr Geneeskd; 2006 Feb; 150(5):275; author reply 275-6. PubMed ID: 16493997
    [No Abstract]   [Full Text] [Related]  

  • 16. [N-acetylcysteine protects against radiocontrast-induced nephropathy -- contra].
    Druml W
    Dtsch Med Wochenschr; 2005 Sep; 130(39):2227. PubMed ID: 16189762
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
    Kramers C; Wetzels J; Natsch S; ten Dam M
    Ned Tijdschr Geneeskd; 2006 Feb; 150(5):274; author reply 275-6. PubMed ID: 16493996
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing contrast-induced nephropathy: a basic solution.
    Bridges JM; Feldstein DA
    WMJ; 2005 Jul; 104(5):9-10. PubMed ID: 16138507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [N-acetylcysteine protects against radiocontrast-induced nephropathy -- pro].
    Weinbrenner C
    Dtsch Med Wochenschr; 2005 Sep; 130(39):2226. PubMed ID: 16189761
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
    Amack Gregoor PJ; van Bommel EF; van der Merulen J; de Jong GM
    Ned Tijdschr Geneeskd; 2006 Feb; 150(5):273-4; author reply 275-6. PubMed ID: 16493995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.